drugset
Drugs / Meningococcal C/Hib vaccine
last change Jun 2021 re-read 2 minutes ago

Meningococcal C/Hib vaccine

also known as MenC/Hib vaccine

Vaccine

Developed for
infectious disease
Investigated by
Public Health England · University College, London · University of Oxford

Trials 1 · a red edge is where a trial was stopped

today NCT02482636 · Ph 2
20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02482636 Aug 2015 → Nov 2017 infectious disease University of Oxford Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Meningococcal C/Hib vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02482636 ↗
Known as MenC/Hib vaccine “Meningococcal C/Hib vaccine (MenC/Hib vaccine)” NCT02482636 ↗
Modality Vaccine “Meningococcal C/Hib vaccine IM 0.5ml at 12 months” NCT02482636 ↗
Route Intramuscular “Meningococcal C/Hib vaccine IM 0.5ml at 12 months” NCT02482636 ↗